Welcome to our dedicated page for American Well SEC filings (Ticker: AMWL), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
American Well Corporation filings document the company’s SaaS-based technology-enabled healthcare platform, operating results, customer agreements, governance, and equity-compensation structure. Its Form 8-K filings include earnings reports for quarterly and annual periods, material definitive agreements, board changes, and related exhibit disclosures.
AMWL filings also describe commercial arrangements tied to digital care delivery, including the company’s operation of a white-labeled platform under the LiveHealth Online brand for Elevance Health and related clinical-provider access through Online Care Group. Proxy materials cover director elections, executive compensation, equity awards, stockholder voting matters, and board governance for the public company.
American Well Corp executive Phyllis Gotlib reported an equity award of company stock. She acquired 50,413 shares of Class A Common Stock as a grant of restricted stock units with a stated price of $0.00 per share. Following this award, she directly holds 166,710 shares.
The RSUs will vest in equal quarterly installments over a two-year period, beginning on the first calendar day of the month after three months from the grant date and continuing until fully vested after 24 months. In addition, 114,250 shares are reported as indirectly owned through her husband.
American Well Corp (AMWL) reported that Chief Product & Tech. Officer Dmitry Zamansky acquired 50,413 shares of Class A Common Stock through a grant or award on March 4, 2026 at a price of $0.00 per share. After this transaction, his directly owned stake in Class A Common Stock totaled 246,655 shares.
According to the footnote, this award represents restricted stock units (RSUs) that vest in equal quarterly installments over two years. Vesting begins on the first calendar day of the month after three months from the grant date and continues quarterly until the first calendar day of the month following the 24‑month anniversary.
McNeice Paul Francis reported acquisition or exercise transactions in this Form 4 filing.
American Well Corp Chief Accounting Officer Paul Francis McNeice reported an equity award of 8,066 shares of Class A common stock on a grant basis at $0.0000 per share. After this grant, he directly holds 10,999 shares of Class A common stock.
The award represents restricted stock units that will vest in equal quarterly installments over two years. Vesting begins on the first calendar day of the month after three months from the grant date and continues until the month following the 24‑month anniversary.
American Well Corp Chief Product & Tech. Officer Dmitry Zamansky sold 2,472 shares of Class A common stock in an open-market transaction at $5.45 per share. The trade was executed under a Rule 10b5-1 trading plan adopted on December 1, 2025, leaving him with 196,242 directly owned shares.
American Well Corp Chief Financial Officer Mark Hirschhorn reported an open-market sale of 10,796 shares of Class A common stock at $5.24 per share. According to the filing, the sale was an automatic “sell to cover” transaction to pay taxes on restricted stock units that vested on March 1, 2026, and not a discretionary trade. After this tax-related sale, he directly holds 203,586 shares.
American Well Corp President, International Phyllis Gotlib sold 3,573 shares of Class A Common Stock in an open-market transaction. The sale took place on March 2, 2026 at a price of $5.24 per share, leaving her with 116,297 shares held directly.
According to the disclosure, this was an automatic “sell to cover” transaction to satisfy tax liabilities from restricted stock units that vested and settled on March 1, 2026. The filing states that the sale did not represent a discretionary trade by the reporting person.
American Well Corp's Chief Accounting Officer, Paul Francis McNeice, reported an open-market sale of 130 shares of Class A common stock at $5.24 per share on March 2, 2026. According to the filing, the sale was an automatic “sell to cover” transaction to pay taxes from restricted stock units vesting on March 1, 2026 and was not a discretionary trade. After this tax-related sale, he directly holds 2,933 shares of Class A common stock.
American Well Corporation submitted a Form 144 notice reporting a proposed sale of 15,890 shares of Class A common stock tied to the vesting of a restricted stock unit grant on 03/01/2026. The filing lists Morgan Stanley (1 New York Plaza) and notes the class trades on the NYSE.
American Well Corporation filed a Form 144 reporting proposed sales of Class A Common Stock.
The notice lists securities-related activity tied to restricted stock unit vesting and prior transfers, including a RSU vesting of 6,786 shares on 03/01/2026 and examples of transfers: Phyllis Gotlib – 3,707 shares on 01/02/2026 and 3,574 shares on 12/01/2025.
Form 144 notice: A Rule 144 notice lists proposed and recent sales of common stock tied to broker Morgan Stanley Smith Barney LLC and an individual, Dmitry Zamansky. The notice shows a past sale of 6,243 common shares on 01/02/2026 for $30,278.55 and a separate listed block of 2,472 common shares dated 04/18/2022.